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We previously mapped a maternal locus responsible for biparental complete hydatidiform moles (BiCHMs) to
19q13.4. The two index patients had a total of 14 molar pregnancies, eight abortions at various developmental
stages, and one 16-year-old healthy offspring. We suggested that the defective gene deregulates the
expression of imprinted genes. Here, we report the methylation status of four imprinted genes in two BiCHMs
from the two sisters, the 16-year-old normal offspring, and two sporadic BiCHMs from unrelated patients.
Using two bisulﬁte-based methods, we demonstrate a general trend of abnormal hypomethylation at the
paternally expressed genes, PEG3 and SNRPN, and hypermethylation at the maternally expressed genes,
NESP55 and H19, in two to four BiCHMs. Using single nucleotide polymorphisms, we provide the ﬁrst
evidence that SNRPN, NESP55 and H19 are abnormally methylated on the maternal alleles in BiCHMs. We
show, in the BiCHMs from the two sisters, that the abnormally methylated H19 allele is inherited from either
the maternal grandmother or the maternal grandfather. These data suggest that the abnormal methylation in
BiCHMs is not due to an error in erasing the parental imprinting marks but rather in the re-establishment of
the new maternal marks during oogenesis or their postzygotic maintenance. The defective 19q13.4 locus may
have led to the development of variable degrees of ‘faulty’ paternal marks on the maternal chromosomes.
INTRODUCTION
Complete hydatidiform moles (CHMs; MIM 231090) are
abnormal human pregnancies characterized by a hydropic
degeneration of all villi and absence of embryo. Most of these
cases are sporadic, not recurrent, and have a diploid genome. In
80% of the cases CHMs have an androgenic genome (AnCHM),
while the remaining 20% have a biparental contribution to the
molar genome (BiCHM) (1). Occasionally, recurrent moles
have been reported in a single family member (2–5) and in a
few cases in more than one family member (6–13).
We previously characterized several CHMs occurring in two
sisters of family MoLb1 and showed a biparental contribution to
the different molar genomes (14). We demonstrated that a
maternal homozygous locus mapping to 19q13.4 is responsible
for the recurrent BiCHMs in MoLb1 (15). We suggested that the
defective maternal gene deregulates the expression of several
imprinted genes. The exact nature of the gene deregulation
underlying HMs and the tissues where the defective product is
needed are unknown yet. However, the occurrence of several
cases of dizygotic twin pregnancies with two separate
conceptuses, a normal placenta attached to one live fetus and
a hydatidiform mole to the other (16), suggests that women with
HMs have normal reproductive tract. In addition, the association
of the beginning and end of the female reproductive period with
the increased incidence of sporadic moles (in women over
45 years and teenagers) (17–22) is in favor of a defect in the
oocytes of women with HMs. The defective gene product may
be needed during gametogenesis in the unfertilized oocytes, or
later after fertilization during early developmental stages.
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Differentially methylated regions (DMRs) between the
maternal and the paternal alleles are one of the best-studied
epigenetic factors associated with the control of imprinted gene
expression. Methylation analysis of several DMRs in one molar
tissue demonstrated the absence of methylation at the six
paternally expressed genes KCNQ1OT1, SNRPN, PEG1,
PEG3, XLas-1A and XLas-antisense; a normal methylation at
the maternally expressed gene, H19; and a high level of
methylation at the maternally expressed NESP55 (12).
However, in this study a single BiCHM was analyzed and the
segregation of the disease phenotype in the analyzed family does
not seem to be linked to 19q13.4, indicating possible genetic
heterogeneity of this disorder. Recently, a second study
demonstrated the abnormal underexpression of one maternally
expressed gene, p57KIP2, in a series of BiCHMs, including two
from sisters in which the defect segregates with alleles at 19q13.4
markers (13).
Here, we report the methylation status of four well-
characterized imprinted genes, the paternally expressed, PEG3
and SNRPN, and the maternally expressed, NESP55 and H19, in
two BiCHMs from two sisters, a 16-year-old healthy girl from
one of them, and two sporadic BiCHMs from unrelated patients.
The aim of our study was to assess the methylation of imprinted,
paternally or maternally expressed genes and investigate whether
different molar tissues occurring in patients from the same family
share similar patterns of abnormal methylation at identical genes.
This would be expected if a specific abnormal methylation is the
primary defect leading to the molar phenotype. In addition, we
analyzed a set of suitable controls including two AnCHMs, and a
series of first trimester chorionic villus cells and total blood from
normal subjects.
We demonstrate a general trend of hypomethylation at the
paternally expressed genes, PEG3 and SNRPN, and an
increased level of methylation at the two maternally expressed
genes, NESP55 and H19. PEG3 and SNRPN were hypomethy-
lated in four and two BiCHMs, respectively; NESP55 and H19
were hypermethylated, respectively, in three and two BiCHMs.
By analyzing SNPs, we provide evidence that the SNRPN,
NESP55 and H19 genes have abnormal patterns of methylation
on the maternal alleles in BiCHMs. We show, in the BiCHMs
from the two sisters, that the abnormally methylated maternal
H19 allele is inherited from either the maternal grandmother or
the maternal grandfather. These data suggest that the abnormal
methylation in BiCHMs is not simply due to an error in erasing
the parental marks, but an error in the reprogramming process
of the maternal marks during oogenesis. Alternatively, an
abnormal postzygotic maintenance of the correctly established
maternal marks may lead to the same situation.
RESULTS
Strategy of methylation analysis
DNAs were treated with bisulfite, PCR amplified and the
methylation was assessed using two independent methods: the
traditional cloning/sequencing method (23) and single nucleotide
primer extension SNuPE followed by separation with ion pair
reverse phase HPLC (SIRPH) (24). The former method provides
detailed information on the methylation status of all CpG
dinucleotides all over the analyzed fragment. When an
informative DNA polymorphism is available, the cloning and
sequencing allow the methylation patterns of the two parental
alleles to be distinguished. However, this method is subject to
cloning and selection bias that may affect the results, especially,
in the absence of polymorphisms, unless a large number of
clones (50–100) are sequenced to reach a statistical result. To
solve this problem, in parallel to the cloning and sequencing
method, we used the SIRPH assay, which provides an accurate
quantitation of the methylation in all the PCR amplified
fragments, but at selected CpG sites. The same outer and nested
primers were used to amplify the same PCR products that were
assessed by the two methods (Supplementary Material, Table 1).
The primers used in the SNuPE are provided (Supplementary
Material, Table 2). To avoid any PCR bias due to allele specific
amplification or extension, we PCR-amplified and sequenced
larger DNA fragments containing each of the analyzed DMRs
including the outer, nested and SNuPE primer sites in untreated
DNA from all the analyzed samples (Supplementary Material,
Table 3). A single nucleotide polymorphism (SNP) at any of
these sites could result in a bias due to a preferential annealing
and amplification or extension of one of the parental alleles and
would change the ratio of the maternal versus paternal alleles
and consequently, the level of methylation in the final products.
The SIRPH analysis has been previously shown to be linear
and quantitative (24). By SIRPH, all studied regions from normal
subjects should have a theoretical 50% methylation like any
imprinted DMR. SIRPH analysis of DNA from total blood and
chorionic villi from normal subjects showed a methylation level
around 40% for the PEG3, 40% for the SNRPN, 20–40% (site 1)
and 40% (site 2) for the NESP55, and 40% for the H19 (Fig. 1).
Some variations in the methylation levels were noted at the
SNRPN and NESP55, but were found only in one to three CVSs
(chorionic villus samples). The two samples of AnCHMs showed
hypomethylation (SNRPN) or unmethylation (PEG3) at the
paternally expressed genes and a clear hypermethylation (80–
100%) at the two paternally repressed genes, NESP55 and H19.
SIRPH analysis on sperm DNA showed, as expected, absence of
methylation at the two paternally expressed PEG3 and SNRPN;
hypermethylation at the paternally repressed H19; and unmethy-
lation (site 1) or a very low level of methylation (site 2, 10%) at
the paternally repressed NESP55, which is known to acquire
paternal imprints in the blastocyst stage (25,26).
Methylation of paternally expressed genes in BiCHMs
Methylation of the PEG3 DMR has been shown to be a
primary imprint occurring in the maternal germ line in mice
(27). Analysis of the molar tissues from MoLb1, BiCHMs 9
and 16 demonstrated their hypomethylation at the PEG3 DMR
by both SIRPH (10–15%; Fig. 1) and cloning/sequencing
(Fig. 2). By SIRPH, BiCHMs 21 and 24 showed a slight
hypomethylation on site 1 (20–25%) and a clear hypomethyla-
tion on site 2 (5–10%). A normal methylation level was
observed in the normal daughter of patient MoLb1– 4. The
SIRPH data were in agreement with those obtained by cloning/
sequencing. No polymorphisms at this DMR were detected in
any of the analyzed samples.
Methylation at the SNRPN DMR 1 is a primary imprint in
mice (28). However, in humans it appears to be established in
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Figure 1. Summary of the quantitative SIRPH methylation analysis at selected CpG sites of the PEG3, SNRPN, NESP55 and H19 DMRs. The average methylation
at each site is represented in a 100% scale. The standard deviation between different measurements is shown as vertical bars. The number of measurements at each
site is shown under each column and represents the number of analyzed PCR products from two independent bisulfite treatments of each DNA.
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late stages of oocyte maturation or even after fertilization (23).
SIRPH analysis of the SNRPN DMR 1 showed a normal
methylation level in BiCHM 9 (30–40%) and BiCHM 21
(50%), while a slight hypomethylation was noted in BiCHMs 16
(20–30%) and 24 (20%; Fig. 1). The cloning/sequencing results
showed a lower level of methylation in the four BiCHMs
(Fig. 2). Using cloning and sequencing, a few fully methylated
clones (with normal maternal pattern of methylation) were
obtained in BiCHMs 9 and 21, and none in BiCHMs 16 (in the
short fragment that does not contain a SNP) and 24. To
understand the differences between the levels of methylation
obtained by SIRPH and cloning/sequencing, we also assessed
the methylation of the same bisulfite-treated and amplified
products using restriction enzyme digestion with two enzymes,
RsaI and MwoI, and quantitation of the digested products using
appropriate software (Quantity One, Bio-Rad). RsaI and MwoI
cut only methylated CpG at sites 3 and 11–12, respectively
(Fig. 2). The results of this analysis showed also some
variability with 5–15% of hypomethylation at RsaI and
10–40% of hypomethylation at MwoI in all the molar samples
(data not shown). This again indicates an irregular scattered,
non-allelic type of methylation at this locus that could explain
the differences in the level of methylation obtained by SIRPH
and sequencing. The search for polymorphisms at this DMR did
not reveal any in BiCHMs 9, 21 and 24. Only one SNP, a C to G,
at position 144772 (GenBank accession no. AC009696) was
found in BiCHM 16 within the forward nested primer site and
was informative to distinguish the parental chromosomes. We
therefore re-amplified and re-analyzed a larger DNA fragment
containing this SNP (Fig. 2). Out of the seven clones from the
maternal chromosome, six were abnormally ummethylated and
only one was fully methylated (normal methylation pattern).
Clones from the paternal chromosome were all, as expected,
ummethylated. We therefore provide a first evidence of an
abnormal unmethylation at the maternal SNRPN DMR in one
molar tissue from MoLb1. A normal methylation level was
found in the healthy daughter of patient MoLb1– 4 by the
SIRPH and cloning/sequencing.
Methylation of maternally expressed genes in BiCHMs
Methylation at the NESP55 DMR is a secondary imprint that is
acquired on the paternal allele in the blastocyst stage (25,26).
BiCHMs 9, 16 and 24 showed a clear hypermethylation (70–
80%), while BiCHM 21 displayed a normal methylation level
(40%; Fig. 1). The search for polymorphisms at this DMR
revealed an A to G polymorphism at position 316 (GenBank
accession no. AF105253 ) located outside the PCR amplified
fragment in BiCHM 9. This SNP was informative to
distinguish the parental alleles and prompted us to re-analyze
a larger DNA fragment in this molar sample (Fig. 3). To our
surprise, the maternal allele, which is supposed to be
unmethylated was fully methylated in four sequenced clones
from BiCHM 9. MoLb1– 4 was homozygous at this SNP, and
therefore we could not assess the grandparental origin of the
abnormally methylated allele. The normal daughter of
MoLb1– 4 showed a normal methylation level. Our data
indicate that the hypermethylation of this DMR in molar
tissues is probably due to the abnormal methylation of the
maternal alleles.
Methylation at the H19 DMR has been shown in humans and
mice to be a primary imprint established during gametogenesis
(29). SIRPH analysis of the H19 DMR showed a normal
methylation level in BiCHMs 9 and 21 (40%), while a clear
hypermethylation was seen in BiCHMs 16 and 24 (60%;
Fig. 1). The healthy daughter of patient MoLb1– 4 had a
normal level of methylation. The search for polymorphisms
revealed the presence of three SNPs, a C to T change at
position 6194, a C to A change at 6236, and an A to G change
at 6325 (in the 50 part of the reverse nested primer; GenBank
accession no. AF087017). The C to A change could be
detected after bisulfite treatment and was informative in most of
the analyzed samples to distinguish the parental alleles.
Cloning and sequencing results revealed that the maternal
chromosome, which is supposed to be unmethylated, displayed
a mixture of variable degrees of methylation with several
clones being fully hypermethylated in the two moles of MoLb1
and the sporadic BiCHM 24 (Fig. 3). Only BiCHM 21
displayed a normal pattern of methylation at this DMR; the
maternal allele was completely unmethylated while the paternal
allele was completely hypermethylated. Sequencing of two
control samples, one CVS and one AnCHM, showed normal
methylation level and pattern in the CVS and hypermethylation
of all clones in the AnCHM, as expected. The normal daughter
of patient MoLb1– 4 had a normal methylation level (40%) and
pattern (Fig. 3).
To investigate the grandparental origin of the abnormally
methylated maternal H19 allele, we sequenced the grand-
parental DNAs of BiCHMs 9 and 16 (the only samples for
which grandparental DNAs are available) and established the
haplotypes at the three H19 SNPs (Fig. 4). Our results show
that the abnormally methylated H19 allele in BiCHM 9 is
inherited from the maternal grandfather, while in BiCHM 16 it
is inherited from the maternal grandmother.
Methylation of one X-linked gene
The abnormal methylation of the analyzed imprinted genes in
BiCHMs prompted us to investigate whether non-imprinted
genes are also abnormally methylated in these tissues. We
chose one non-imprinted gene, the factor VIII (F8) that we
previously characterized and showed its hypermethylation in
mature female and male germ cells (30). SIRPH analysis of one
CpG in exon 23 of the F8 (GenBank accession no. M88645)
showed a normal high level of methylation (80–90%) in all the
analyzed molar and control samples (data not shown).
DISCUSSION
A homozygous maternal mutation deregulating the expression
of imprinted genes is believed to underlie the pathology of
familial BiCHMs. To address this hypothesis, we investigated
the methylation status of four well-characterized DMRs
controlling the expression of imprinted, paternally or mater-
nally expressed genes in three conceptuses of a previously
reported family MoLb1 (14), two BiCHMs from two sisters as
well as a 16-year-old healthy daughter from one of them, and
two sporadic BiCHMs from unrelated patients. The methyla-
tion status was assessed using two methods, bisulfite treatment
of the DNA followed by PCR amplification, cloning and
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Figure 2. Summary of the methylation analysis from the isolated sequenced clones at the imprinted, paternally expressed genes PEG3 and SNRPN. The accession
numbers of the sequences are indicated for each gene with the extent of the analyzed region. Solid boxes represent coding regions in the vicinity of the DMR.
Horizontal arrows indicate the transcriptional direction. Vertical arrows indicate CpG sites analyzed by SIRPH. Each line represents an independent original
DNA strand; the solid and open circles represent methylated and unmethylated CpG, respectively. At the SNRPN, clones containing the SNP (at position
144772 in GenBank accession no. AC009696) are grouped together according to their maternal (M) and paternal (P) origin.
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Figure 3. Summary of the methylation analysis from the isolated sequenced clones at the imprinted, maternally expressed genes NESP55 and H19. The accession
numbers of the sequences are indicated for each gene with the extent of the analyzed region. Solid boxes represent the transcripts in the vicinity of the studied
region. Horizontal arrows represent the direction of transcription. Vertical arrows indicate CpG sites analyzed by SIRPH. Each line represents an independent
original DNA strand; the solid and open circles represent methylated and unmethylated CpG, respectively. Clones from DNA fragments containing informative
SNPs (position 316 in GenBank accession no. AF105253 for NESP55 and positions 6194, 6236 and 6325 in GenBank accession no. AF087017 for H19) are
grouped together and labeled according to their maternal (M) or paternal (P) origin.
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sequencing or SIRPH analysis. Our data indicate that both
methods are complementary; their combination allows a better
assessment of the methylation level. Here, we show a general
trend of decreased level of methylation at the paternally
expressed genes, with PEG3 hypomethylated in the four
BiCHMs and SNRPN hypomethylated in two BiCHMs
(samples 16 and 24), and an increased level of methylation at
the two maternally expressed genes, with NESP55 hypermethy-
lated in three BiCHMs (samples 9, 16 and 24) and H19
hypermethylated in two BiCHMs (samples 16 and 24). Using
informative DNA polymorphisms, we demonstrated that the
maternal alleles of the three imprinted genes SNRPN, NESP55
and H19 display variable degrees of paternal methylation
patterns in BiCHMs. This is in agreement with the pathology of
BiCHMs, which leads to the same phenotype observed in
AnCHMs. Consequently, the maternal alleles of imprinted
genes, although present in the molar genome of BiCHMs,
behave as their paternal homologs. Our data on the H19 and
NESP55 are in agreement with the underexpression of the
p57KIP2 gene in two BiCHMs from a family in which the
disease phenotype is linked to 19q13.4 (13). One of our
sporadic cases, BiCHM 21, showed a normal methylation level
and pattern at the maternally expressed H19. A similar normal
methylation at this gene was also reported in another case of
BiCHM from a familial case that is not linked to 19q13.4.
However, in the latter, the NESP55 was hypermethylated and
the two paternally expressed genes PEG3 and SNRPN were
completely ummethylated (12). In the four BiCHMs we
analyzed, the abnormally methylated genes have an intermedi-
ate level of methylation between normal chorionic villi and
AnCHMs. Despite these methylation differences, BiCHMs and
AnCHMs are phenotypically undistinguishable at the histo-
pathological level. This may be due to the fact that embryonic
development in CHMs is arrested at an early stage, probably
after the formation of the primary trophoblast and before the
formation of fetal tissues. Consequently, even if different
molecular defects lead to the different types of moles, the
absence of differentiated fetal tissues and structures makes it
very difficult to divide moles into phenotypic categories.
Altogether, these data indicate that the pathology of moles may
not be explained by a single mechanism, but rather by a
cumulative effect of gene deregulation at multiple loci leading
to early embryonic lethality and proliferation of the trophoblast.
Our results on one X-linked gene, the F8, showed a normal
methylation in all BiCHMs. Nevertheless, the analysis of
additional non-imprinted genes is needed to reach a conclusion
on their methylation status in BiCHMs.
From our data on the four imprinted DMRs in BiCHMs,
there is a general tendency, in most of the samples, for a switch
from the maternal methylation patterns to the paternal
methylation patterns. This abnormal methylation could have
happened at one of the following developmental stages: (i) in
the molar tissues during the proliferation of the trophoblast; (ii)
very early in the zygotes due to a failure in maintaining the
correct imprinting marks; (iii) during the oocyte growth of
patients with BiCHMs, as a result of an error in the
reprogramming process and the re-establishment of the
maternal methylation marks; (iv) or in the primordial germ
cells of these patients due to a failure in erasing their parental
imprinting marks. From our analysis, it is impossible to
determine the exact developmental stage at which this
abnormal methylation occurred. However, the presence of
similar patterns of hypo- and hypermethylation at identical
genes in the two moles from sisters who share the same genetic
defect and in one sporadic case suggests that this abnormal
methylation is not a consequence of the trophoblastic
proliferation, but a primary defect leading to the molar
phenotype. In addition, the inheritance of the abnormally
methylated maternal H19 allele from either the maternal
grandfather or grandmother (Fig. 4) suggests that the abnormal
methylation is not due to an error in erasing the imprinting
marks, but rather in the reprogramming process and the
re-establishment or the postzygotic maintenance of the new
maternal marks. The defective 19q13.4 locus may have led to
variable degrees of ‘faulty’ paternal imprinting marks on the
maternal alleles.
Altered gene methylation and expression of several imprinted
genes (Igf2, H19, Peg1/Mest and Meg1/Grb10) is found in
cloned animals obtained by various methods of nuclear transfer
(31). Despite the improvement of these methods and the recent
successes in cloning several animal species, most of the cloned
embryos die at various developmental stages and only 1–5%
live to term. These latter have a normal phenotype despite
widespread imprinted gene deregulation, indicating that
mammalian development is tolerant to epigenetic aberrations
and that normal cloned animals may or may not have changes in
gene expression (31–33). In family MoLb1, the three patients
had a total of 14 HMs (13 complete HMs and one partial HM,
see Patient materials), eight abortions of various stages, and one
normal pregnancy that led to a live term baby, now a 16-year-
old healthy girl whose DNA was included in this study. Analysis
of the four DMRs on total blood DNA from this individual did
not reveal any abnormalities in the level of DNA methylation.
Figure 4. Partial pedigree of MoLb1 family showing the grandparental origin
of the abnormally methylated maternal allele transmitted to the moles at the
H19 DMR. The haplotypes were constructed at the three SNPs (positions
6194, 6236 and 6325 in GenBank accession no. AF087017) assuming the
absence of recombination events.
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Our data on the three conceptuses of MoLb1 suggest that
the defective 19q13.4 locus leads to variable degrees of
imprinting deregulation on the maternal allele during oogenesis
or early development. The variability of the phenotype of the
conceptuses will then depend on the degree and the importance
of the deregulated genes. Occasionally, critical genes for
normal development escape the deregulation and lead to
normal live term birth. Analysis of the methylation of
additional imprinted and non-imprinted genes in the different
types of the conceptuses of MoLb1 patients will provide a
comprehensive assessment of gene deregulation caused by the
defective 19q13.4 locus.
MATERIALS AND METHODS
Patient materials
Six HMs, two from the two sisters of family MoLb1 (14) and
four sporadic HMs from unrelated patients were analyzed. The
molar tissues from MoLb1 were from patient 4 (BiCHM 9, 14
weeks of gestation) and from patient 6 (BiCHM 16, 7.6 weeks
of gestation). The complete pedigree and clinical data of
MoLb1 were previously described (14). Since that time, only
patient MoLb1–4 had one partial hydatidiform mole and one
abortion at 8 weeks of gestation. The sporadic moles were from
cases 21, 24, 23 and 28, each with a single HM. All HM DNAs
were obtained from uncultured freshly dissected villi.
Dissections were performed carefully under a stereomicro-
scope. The dissected tissues were then washed several times
with 1PBS and used to extract DNAs according to standard
phenol–chloroform protocols. DNA from total blood from a
16-year-old healthy daughter of patient MoLb1– 4 was also
included (this offspring has never been pregnant and her
phenotype status is unknown). In addition, DNAs from seven
chorionic villus and eight total blood samples from unrelated
healthy subjects were used as controls. The chorionic villus
samples were obtained from cases referred for prenatal
diagnosis for mutations in the Duchenne muscular dystrophy
or the spinal muscular atrophy genes. All the DNA samples
were obtained from chorionic villous sampling cells that were
not cultured. Their respective gestational stages are indicated in
Figure 1. All the analyzed HMs are of complete type according
to standard pathological criteria.
Genotyping
The two molar tissues from MoLb1 (BiCHMs 9 and 16) were
previously shown to be diploid with biparental contribution
(14). DNA from the four CHMs (samples 21, 24, 23 and 28)
and their available parents were genotyped at six to 19 markers
from at least six autosomes (34) (Supplementary Material,
Table 4). Two CHMs, samples 21 and 24, were found to be
biparental. In addition, sample 21 was previously shown to be
of biparental origin by RFLP analysis of the HLA locus
on Southern blots (P. Coullin, unpublished data). Two CHMs,
samples 23 and 28, were found to be androgenetic mono-
spermic. Sample 23 had also been previously reported to be
androgenetic by HLA serological typing (35). The genotypes at
the other markers were in agreement with either a biparental
(for cases 21 and 24) or an androgenetic monospermic
contribution (for cases 23 and 28). No contamination
with maternal tissues was noted in the molar DNA samples
at any informative microsatellite markers and SNPs
(Supplementary Material, Table 4 and Fig. 5). Because no
other family members were available from the sporadic cases
BiCHMs 21, 24, 23 and 28, we could not assess the segregation
of the disease phenotype with markers from the HMs 19q13.4
candidate region. The analyzed markers from this region
were not homozyogous in the patients with BiCHMs
(Supplementary Material, Table 4).
Bisulfite treatment
Bisulfite treatment of the DNA was done as previously
described (36). Briefly, we digested 50–100 ng of DNA with
EcoRI (total volume of 21 ml). We denatured the DNA by
mixing it with 4 ml of 2 M NaOH and incubation at 50C for
15 min. After mixing with hot 2% low melting agarose, we
formed the DNA–agarose beads by pipeting 10 ml of this
mixture in ice-cold heavy mineral oil (Sigma). After the
solidification of the beads, we added 500 ml of a 2.5 M sodium
metabisulfite (Merck), 125 mM hydroquinone (Sigma) pH 5.0.
We incubated the tubes for 30 min on ice then for 3 h 30 min at
50C in the dark. The beads were washed four times in 1TE
(pH 8.0), treated twice with 0.2 M NaOH for 15 min, and
washed twice with 1TE for 10 min each. Prior to PCR
amplification, the beads were washed twice with H2O for
10 min each, and melted at 70C for 10 min. Five microliters of
this melted agarose were used in each 50 ml PCR reaction. We
performed all PCRs in two rounds of amplification to increase
the specificity for the amplification of fully bisulfite-converted
templates. Most samples have been subject to two independent
bisulfite treatments and were analyzed from two independent
PCR products.
SIRPH analysis
We performed the SIRPH as previously described (24). Briefly,
to remove the unreacted PCR oligonucleotides and excess of
dNTPs, we purified the PCR product using QIAquick
gel extraction kit (Qiagen). We prepared the SNuPE reaction
by mixing 100 ng of PCR product, 12 pmol of the SNuPE
oligonucleotides, 50 mM of each ddCTP and ddTTP
(Amersham), three units of thermosequenase (Amersham) in
a total volume of 20 ml. This mixture was then incubated for 60
cycles as follows: 15 s 92C, 15 s 30C and 1 min 60C. Then
we directly loaded the SNuPE product on the dHPLC machine
(Wave from Transgenomics) to separate the extended products
and quantitatively measure their corresponding peaks. The
oligonucleotides used in the SNuPE reaction and the dHPLC
conditions are listed in Table 2 (Supplementary Material). The
SIRPH analysis was performed more than once on most
products.
Cloning and sequencing
We used QIAquick gel extraction kit (Qiagen) to purify the
amplified products, followed by cloning in pGEM-T Easy TA
vector (Promega). Five to 50 insert-containing clones were
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sequenced from each DMR using vector primers on an
automated ABI 3700 capillary sequencer (Montreal General
Hospital, Genome Quebec).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
ACKNOWLEDGEMENTS
We thank the patients for their cooperation. We would like to
thank Y. Bou Moglabey for technical support and Jo¨rg
Schro¨der and Barbara Kellner for data on CVS samples. This
work was supported by start-up funds from the Research
Institute of the McGill University Health Centre to R.S. and by
a BONFOR grant (O-145.0004).
REFERENCES
1. Kovacs, B.W., Shahbahrami, B., Tast, D.E. and Curtin, J.P. (1991)
Molecular genetic analysis of complete hydatidiform moles. Cancer Genet.
Cytogenet., 54, 143–152.
2. Patek, E. and Johnson, P. (1978) Recurrent hydatidiform mole. Report of a
case with five recurrences. Acta Obstet. Gynecol. Scand., 57, 381–383.
3. Neumann, H. (1980) [Case report of recurring hydatidiform mole (author’s
translation).] Geburtshilfe Frauenheilkd, 40, 385–388.
4. Narayan, H., Mansour, P. and McDougall, W.W. (1992) Recurrent
consecutive partial molar pregnancy. Gynecol. Oncol., 46, 122–127.
5. Ozalp, S., Yalcin, O.T., Tanir, H.M. and Etiz, E. (2001) Recurrent molar
pregnancy: report of a case with seven consecutive hydatidiform moles.
Gynecol. Obstet. Invest., 52, 215–216.
6. Ambani, L.M., Vaidya, R.A., Rao, C.S., Daftary, S.D. and Motashaw, N.D.
(1980) Familial occurrence of trophoblastic disease—report of recurrent
molar pregnancies in sisters in three families. Clin. Genet., 18, 27–29.
7. La Vecchia, C., Franceschi, S., Fasoli, M. and Mangioni, C. (1982)
Gestational trophoblastic neoplasms in homozygous twins. Obstet.
Gynecol., 60, 250–252.
8. Parazzini, F., La Vecchia, C., Franceschi, S. and Mangili, G. (1984) Familial
trophoblastic disease: case report. Am. J. Obstet. Gynecol., 149, 382–383.
9. Kircheisen, R. and Ried, T. (1994) Hydatidiform moles. Hum. Reprod.,
9, 1783–1784.
10. Seoud, M., Khalil, A., Frangieh, A., Zahed, L., Azar, G. and
Nuwayri-Salti, N. (1995) Recurrent molar pregnancies in a family with
extensive intermarriage: report of a family and review of the literature.
Obstet. Gynecol., 86, 692–695.
11. Sensi, A., Gualandi, F., Pittalis, M.C., Calabrese, O., Falciano, F., Maestri, I.,
Bovicelli, L. and Calzolari, E. (2000) Mole maker phenotype: possible
narrowing of the candidate region. Eur. J. Hum. Genet., 8, 641–644.
12. Judson, H., Hayward, B.E., Sheridan, E. and Bonthron, D.T. (2002) A
global disorder of imprinting in the human female germ line. Nature,
416, 539–542.
13. Fisher, R.A., Hodges, M.D., Rees, H.C., Sebire, N.J., Seckl, M.J.,
Newlands, E.S., Genest, D.R. and Castrillon, D.H. (2002) The maternally
transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both
androgenetic and biparental complete hydatidiform moles. Hum. Mol.
Genet., 11, 3267–3272.
14. Helwani, M.N., Seoud, M., Zahed, L., Zaatari, G., Khalil, A. and Slim, R.
(1999) A familial case of recurrent hydatidiform molar pregnancies with
biparental genomic contribution. Hum. Genet., 105, 112–115.
15. Moglabey, Y.B., Kircheisen, R., Seoud, M., El Mogharbel, N.,
Van den Veyver, I. and Slim, R. (1999) Genetic mapping of a maternal
locus responsible for familial hydatidiform moles. Hum. Mol. Genet., 8,
667–671.
16. Vejerslev, L.O. (1991) Clinical management and diagnostic possibilities
in hydatidiform mole with coexistent fetus. Obstet. Gynecol. Surv., 46,
577–588.
17. Javey, H. and Sajadi, H. (1978) Hydatidiform mole in southern Iran:
a statistical survey of 113 cases. Int. J. Gynaecol. Obstet., 15,
390–395.
18. Jacobs, P.A., Hunt, P.A., Matsuura, J.S., Wilson, C.C. and Szulman, A.E.
(1982) Complete and partial hydatidiform mole in Hawaii: cytogenetics,
morphology and epidemiology. Br. J. Obstet. Gynaecol., 89, 258–266.
19. Matsuura, J., Chiu, D., Jacobs, P.A. and Szulman, A.E. (1984) Complete
hydatidiform mole in Hawaii: an epidemiological study. Genet. Epidemiol.,
1, 271–284.
20. Mazzanti, P., La Vecchia, C., Parazzini, F. and Bolis, G. (1986)
Frequency of hydatidiform mole in Lombardy, Northern Italy. Gynecol.
Oncol., 24, 337–342.
21. Bracken, M.B. (1987) Incidence and aetiology of hydatidiform mole: an
epidemiological review. Br. J. Obstet. Gynaecol., 94, 1123–1135.
22. Sebire, N.J., Rees, H., Paradinas, F., Seckl, M. and Newlands, E. (2001)
The diagnostic implications of routine ultrasound examination in
histologically confirmed early molar pregnancies. Ultrasound Obstet.
Gynecol., 18, 662–665.
23. El-Maarri, O., Buiting, K., Peery, E.G., Kroisel, P.M., Balaban, B.,
Wagner, K., Urman, B., Heyd, J., Lich, C., Brannan, C.I. et al. (2001)
Maternal methylation imprints on human chromosome 15 are established
during or after fertilization. Nat. Genet., 27, 341–344.
24. El-Maarri, O., Herbiniaux, U., Walter, J. and Oldenburg, J. (2002) A
rapid, quantitative, non-radioactive bisulfite-SNuPE-IP RP HPLC
assay for methylation analysis at specific CpG sites. Nucl. Acids Res.,
30, e25.
25. Hayward, B.E. and Bonthron, D.T. (2000) An imprinted antisense transcript
at the human GNAS1 locus. Hum. Mol. Genet., 9, 835–841.
26. Liu, J., Yu, S., Litman, D., Chen, W. and Weinstein, L.S. (2000)
Identification of a methylation imprint mark within the mouse Gnas locus.
Mol. Cell. Biol., 20, 5808–5817.
27. Lucifero, D., Mertineit, C., Clarke, H.J., Bestor, T.H. and Trasler, J.M.
(2002) Methylation dynamics of imprinted genes in mouse germ cells.
Genomics, 79, 530–538.
28. Shemer, R., Birger, Y., Riggs, A.D. and Razin, A. (1997) Structure of the
imprinted mouse Snrpn gene and establishment of its parental-specific
methylation pattern. Proc. Natl Acad. Sci. USA, 94, 10267–10272.
29. Kerjean, A., Dupont, J.M., Vasseur, C., Le Tessier, D., Cuisset, L., Paldi, A.,
Jouannet, P. and Jeanpierre, M. (2000) Establishment of the paternal
methylation imprint of the human H19 and MEST/PEG1 genes during
spermatogenesis. Hum. Mol. Genet., 9, 2183–2187.
30. El-Maarri, O., Olek, A., Balaban, B., Montag, M., van der Ven, H.,
Urman, B., Olek, K., Caglayan, S.H., Walter, J. and Oldenburg, J. (1998)
Methylation levels at selected CpG sites in the factor VIII and FGFR3
genes, in mature female and male germ cells: implications for male-driven
evolution. Am. J. Hum. Genet., 63, 1001–1008.
31. Humpherys, D., Eggan, K., Akutsu, H., Hochedlinger, K., Rideout, W.M., III,
Biniszkiewicz, D., Yanagimachi, R. and Jaenisch, R. (2001) Epigenetic
instability in ES cells and cloned mice. Science, 293, 95–97.
32. Rideout, W.M., III, Eggan, K. and Jaenisch, R. (2001) Nuclear cloning
and epigenetic reprogramming of the genome. Science, 293,
1093–1098.
33. Inoue, K., Kohda, T., Lee, J., Ogonuki, N., Mochida, K., Noguchi, Y.,
Tanemura, K., Kaneko-Ishino, T., Ishino, F. and Ogura, A. (2002) Faithful
expression of imprinted genes in cloned mice. Science, 295, 297.
34. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A.,
Millasseau, P., Marc, S., Hazan, J., Seboun, E. et al. (1996) A
comprehensive genetic map of the human genome based on 5,264
microsatellites. Nature, 380, 152–154.
35. Couillin, P., Ravise´, N., Afoutou, J.M., Chaibi, R., Azoulay, M., Hors, J.,
Oury, J.F., Boue´, J. and Boue´, A. (1987) HLA et grossesses molaires
(triploı¨dies, mo¨les hydatiformes, choriocarcinome). Etudes e´tiologique et
e´pide´miologique. Ann. Genet., 30, 197–208.
36. Hajkova, P., El-Maarri, O., Engemann, S., Oswald, J., Olek, A. and Walter, J.
(2002) DNA-methylation analysis by the bisulfite-assisted genomic
sequencing method. Meth. Mol. Biol., 200, 143–154.
Human Molecular Genetics, 2003, Vol. 12, No. 12 1413
Downloaded from https://academic.oup.com/hmg/article-abstract/12/12/1405/602045/Maternal-alleles-acquiring-paternal-methylation
by Lebanese American University user
on 12 September 2017
